Search Results Search Sort by RelevanceMost Recent Policy Forum Nov 2021 Four Ways to Limit Use of Force in Care of Persons Experiencing Homelessness Mary L. Tornabene, MSN, APRN, FNP-BC and Alyssa S. Tornabene, RN Involuntary commitment is often traumatic and can fracture already fragile relationships persons experiencing homeless have. AMA J Ethics. 2021;23(11):E869-874. doi: 10.1001/amajethics.2021.869. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Policy Forum Oct 2003 Psychotropic Medications and Criminal Defendants Robert M. Wettstein, MD Virtual Mentor. 2003;5(10):455-459. doi: 10.1001/virtualmentor.2003.5.10.pfor1-0310 Policy Forum Oct 2023 How Should We Address Warehousing Persons With Serious Mental Illness in Nursing Homes? Ari Ne’eman This article suggests how to better identify older adults with mental illness at risk for placement that won’t meet their needs. AMA J Ethics. 2023;25(10):E758-764. doi: 10.1001/amajethics.2023.758.
Policy Forum Nov 2021 Four Ways to Limit Use of Force in Care of Persons Experiencing Homelessness Mary L. Tornabene, MSN, APRN, FNP-BC and Alyssa S. Tornabene, RN Involuntary commitment is often traumatic and can fracture already fragile relationships persons experiencing homeless have. AMA J Ethics. 2021;23(11):E869-874. doi: 10.1001/amajethics.2021.869.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Policy Forum Oct 2003 Psychotropic Medications and Criminal Defendants Robert M. Wettstein, MD Virtual Mentor. 2003;5(10):455-459. doi: 10.1001/virtualmentor.2003.5.10.pfor1-0310
Policy Forum Oct 2023 How Should We Address Warehousing Persons With Serious Mental Illness in Nursing Homes? Ari Ne’eman This article suggests how to better identify older adults with mental illness at risk for placement that won’t meet their needs. AMA J Ethics. 2023;25(10):E758-764. doi: 10.1001/amajethics.2023.758.